Table 2.
Parameters | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
PFS | OS | PFS | OS | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
CD68+ %area* | 1.08 (1.00–1.15) | 0.04 | 1.04 (0.96–1.12) | 0.34 | 1.14 (0.96–1.38) | 0.14 | 1.09 (0.87–1.35) | 0.39 |
CD163+ %area* | 1.06 (0.998–1.12) | 0.05 | 1.03 (0.96–1.09) | 0.37 | 0.95 (0.81–1.12) | 0.56 | 0.93 (0.78–1.11) | 0.41 |
CD204+ %area* | 1.06 (0.95–1.18) | 0.28 | 1.04 (0.91–1.16) | 0.52 | 1.01 (0.81–1.24) | 0.89 | 1.09 (0.87–1.35) | 0.45 |
Age (years)* | 1.01 (0.96–1.05) | 0.63 | 1.01 (0.96–1.06) | 0.53 | 0.97 (0.92–1.03) | 0.42 | 0.98 (0.91–1.04) | 0.43 |
Sex (male : female) | 1.53 (0.68–3.25) | 0.28 | 1.62 (0.64–3.81) | 0.29 | 1.08 (0.91–1.30) | 0.09 | 1.70 (0.59–4.68) | 0.31 |
Number of tumor (m : s) | 2.36 (1.13–5.12) | 0.02 | 1.74 (0.80–3.93) | 0.15 | 1.00 (0.86–1.18) | 0.03 | 1.79 (0.68–4.87) | 0.23 |
PS* | 1.51 (0.98–2.30) | 0.06 | 2.07 (1.33–3.21) | 0.001 | 1.57 (0.94–2.63) | 0.08 | 2.39 (1.39–4.22) | 0.001 |
*Continuous variables.
P‐value < 0.05 was considered to be statistically significant in bold.